{
    "code": 0,
    "data": [
        {
            "co_code": 94649,
            "bse_code": 544666,
            "isin": "INE0V0W01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting Rescheduled",
            "caption": "Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting",
            "news_body": "Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve  and take on record the Un-Audited  standalone and consolidated Financial Results of the Company for the quarter ended December 31 2025 and any other business with the permission of the Chair.\r\nWith reference to the earlier announcement dated February 10 2026 pursuant to the provisions of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations 2015 this is to inform you that due to unavoidable circumstances the Meeting of Board of Directors which was scheduled to be held on Friday February 13 2026 is now postponed and re-scheduled on Saturday February 14 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf7b9f00-07d0-44fc-92d7-969447cad210.pdf",
            "news_date": "2026-02-11 17:38:33"
        },
        {
            "co_code": 94649,
            "bse_code": 544666,
            "isin": "INE0V0W01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for  Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31 2025 and any other business if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1507d43-c072-434a-bf47-9538db2e32c5.pdf",
            "news_date": "2026-02-10 17:56:38"
        },
        {
            "co_code": 94649,
            "bse_code": 544666,
            "isin": "INE0V0W01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Board Meeting Hold On 5Th February 2026.",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Thursday  5th February 2026 (which commenced at 3:30 p.m. and concluded at 4:30 .p.m.) inter alia has approved the following:-\r\n1) APPROVAL FOR TO MAKE INVESTMENT IN PATEL PHARMACY.\r\n2) APPROVAL FOR TO MAKE INVESTMENT IN PATEL MULTISPECIALITY HOSPITAL AND ICU. \r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c766e88f-e0d5-4038-a228-939a00053cac.pdf",
            "news_date": "2026-02-05 17:35:44"
        },
        {
            "co_code": 94649,
            "bse_code": 544666,
            "isin": "INE0V0W01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed Certificate under Regulation 74(5) under SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st December2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c716c0a-9b00-439d-bd74-736ba3cc0c59.pdf",
            "news_date": "2026-01-10 09:14:35"
        },
        {
            "co_code": 94649,
            "bse_code": 544666,
            "isin": "INE0V0W01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Hold On 6Th January 2026.",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Tuesday  6th January 2025 (which commenced at 5:00 p.m. and concluded at 6:00 .p.m.) inter alia has approved the following:-\r\n1) APPROVAL FOR AQUIRE REMAINING 49% SHARES OF M/S. HARMONY MEDICARE PRIVATE LIMITED AND TO MAKE THEM AS WHOLLY OWNED SUBSIDIARY COMPANY.\r\n\r\n2) ACCORDING TO ACQUISITION AGREEMENT AND THE ACQUISITION AGREEMENT-II AND OBJECT OF THE ISSUE OF INITIAL PUBLIC OFFERING THE BOARD OF DIRECTORS APPROVED TO MAKE PART PAYMENT OF RS. 1240 LAKHS AS PURCHASE CONSIDERATION FOR THE ALREADY ACQUIRED ASHWINI MEDICAL CENTRE\r\n\r\n\r\n\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ca453bf-9d00-43a3-8011-e4b9f1285f28.pdf",
            "news_date": "2026-01-06 18:56:47"
        },
        {
            "co_code": 94649,
            "bse_code": 544666,
            "isin": "INE0V0W01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 2Nd January 2026",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Friday 2nd January 2025 (which commenced at 10:00 a.m. and concluded at 11:00 a.m.) inter alia has approved the following:-\r\n1) APPROVAL FOR ACQUISITION OF 100% EQUITY STAKE IN PAREKHS HOSPITAL PRIVATE LIMITED AND FOR EXECUTION OF SHARE PURCHASE AGREEMENT WITH THE PROMOTER GROUP OF PAREKHS HOSPITAL PRIVATE LIMITED :\r\n\r\nThe Board of Directors has approved the purchase / acquisition of 100% Equity Stake in Parekhs Hospital Private Limited  to make that Company as a wholly owned subsidiary of the Company.. \r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b2c79f6-fbf8-4849-b2d8-323103b7b5a0.pdf",
            "news_date": "2026-01-02 11:11:30"
        },
        {
            "co_code": 94649,
            "bse_code": 544666,
            "isin": "INE0V0W01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window for quarter ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe45e989-5139-403b-8373-2cd6a7fa1cee.pdf",
            "news_date": "2025-12-30 16:28:35"
        },
        {
            "co_code": 94649,
            "bse_code": 544666,
            "isin": "INE0V0W01025",
            "ann_type": "General",
            "descriptor": "New Listing",
            "caption": "Listing of Equity Shares of Gujarat Kidney and Super Speciality Ltd",
            "news_body": "Trading Members of the Exchange are hereby informed that effective from December 30 2025 the Equity Shares of Gujarat Kidney and Super Speciality Ltd (Scrip Code: 544666) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no. 20251229- dated December 29 2025.",
            "file_url": "",
            "news_date": "2025-12-30 08:05:31"
        }
    ]
}